Derouane daphne (4 résultats)

- Couverture rigide
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 232,77
EUR 6,85 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : Plus de 20 disponibles
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000.

- Couverture rigide
Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 239,80
Frais de port gratuitsExpédition nationale : Etats-UnisQuantité disponible : Plus de 20 disponibles
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000.

- Couverture rigide
Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 332,95
EUR 64,61 expéditionExpédition depuis Allemagne vers Etats-UnisQuantité disponible : 2 disponible(s)
Buch. Etat : Neu. Neuware.

- Couverture rigide
- impression à la demande
Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail
Contacter le vendeurVendeur avec une évaluation de 5 étoilesEtat: Neuf
EUR 243,39
EUR 43,18 expéditionExpédition depuis Royaume-Uni vers Etats-UnisQuantité disponible : 1 disponible(s)
Hardcover. Etat : new. Hardcover. This book explores one of the most contested and thought-provoking questions in patent law: the limits of patent protection. At the heart of this debate lie two crucial legal exemptions-the Experimental Use exemption and the Bolar-type exemption-both of which strike delicate balances between pri…vate rights and the public good. The Experimental Use exemption, with roots in 19th-century case law, was designed to foster technological progress by excepting research and innovation from the realm of patent infringement. By contrast, the Bolar-type exemption emerged in the 1980s in response to the public interest in offering affordable medicines, represented by the generic pharmaceutical industry. Their distinct rationales have led to diverging interpretations and implementations across the globe, creating uncertainty for legislators, innovators, and industry alike. Through analysis of landmark cases, statutory developments, and comparative insights from many jurisdictions over the world, the book reveals the ongoing tensions between innovation policy, access to medicines, and the harmonization of international patent law. It also highlights new challenges posed by emerging technologies such as biologics and biosimilars, which further complicate the scope of these exemptions. A vital resource for legislators, policymakers, patent practitioners, and scholars, this book provides essential guidance on navigating the complexities of infringement exemptions worldwide. It will also serve as an indispensable reference for global companies advising their R&D organizations in a fragmented legal landscape. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.